SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $425,109 | -17.0% | 14,142 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $512,365 | -8.3% | 14,142 | -9.7% | 0.01% | 0.0% |
| Q4 2022 | $558,913 | -42.4% | 15,669 | -50.3% | 0.01% | -37.5% |
| Q2 2021 | $970,000 | +17.6% | 31,500 | 0.0% | 0.01% | +14.3% |
| Q1 2021 | $825,000 | +4.0% | 31,500 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $793,000 | -14.3% | 31,500 | -29.1% | 0.01% | -30.0% |
| Q3 2020 | $925,000 | +36.2% | 44,400 | +55.2% | 0.01% | +25.0% |
| Q2 2020 | $679,000 | -20.3% | 28,600 | +53.8% | 0.01% | 0.0% |
| Q1 2018 | $852,000 | – | 18,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |